Selling a cosmetic product in the European Union requires more than adapting a U.S. label or shipping existing inventory overseas. A U.S. brand needs a defined EU compliance pathway before the product is placed on the market. That pathway typically includes an EU-based Responsible Person, a Cosmetic Product Safety Report (CPSR), a Product Information File (PIF), notification through the Cosmetic Products Notification Portal (CPNP), compliant labeling and manufacturing documentation.
This EU cosmetics compliance checklist is designed for U.S. beauty brands that already have a formula—or are developing one—and want to understand what must be organized before an EU launch. It is not a history of European regulation. Instead, it focuses on the documents, responsibilities and decisions that can affect launch readiness.
For broader background on how MedPak supports brands navigating European cosmetic regulation, review MedPak’s existing EU compliance resource. The checklist below focuses specifically on the operational launch sequence.
The governing framework is Regulation (EC) No 1223/2009 on cosmetic products. The exact compliance work depends on the product, ingredients, claims, packaging and the EU countries where it will be sold.
A formula that is already sold in the United States should not automatically be treated as EU-ready. Ingredient restrictions, maximum concentrations, conditions of use and labeling requirements can differ. Before spending heavily on packaging or launch inventory, review the full formula against current EU requirements.
A practical pre-review should confirm:
Why this matters: if an ingredient or claim must change, that change can affect stability work, safety assessment, artwork, packaging and the launch schedule. Regulatory review is therefore most efficient before the brand locks the final production version.
Under Regulation (EC) No 1223/2009, a cosmetic product may be placed on the EU market only when a legal or natural person established in the EU is designated as the Responsible Person for that product. For imported cosmetics, the importer is generally the Responsible Person unless another EU-established person is designated by written mandate and accepts that role.
The EU cosmetic Responsible Person is not simply a mailing address. The role carries compliance responsibilities that connect the product, safety documentation, notification, labeling and authorities.
Before launch, the brand should document:
For a U.S. brand, choosing the RP early is useful because the RP is connected to the CPSR, PIF, CPNP submission and label review.
Before a cosmetic product is placed on the EU market, the Responsible Person must ensure that the product has undergone a safety assessment and that a Cosmetic Product Safety Report (CPSR) is prepared in accordance with Annex I of the Cosmetics Regulation.
This is more than a basic ingredient list. The safety assessment considers the finished product, intended use and relevant exposure information. The assessment must be performed by a person with the qualifications specified by the Regulation, such as an appropriate university qualification in pharmacy, toxicology, medicine or a similar discipline, or an equivalent qualification recognized by a Member State.
Information commonly needed for CPSR preparation can include:
A common planning mistake is treating the CPSR as a final administrative form. If the safety assessor identifies a formulation, exposure or documentation issue, the brand may need additional data or product changes. Build time for that review into the launch plan.
When the product is placed on the market, the Responsible Person must keep a Product Information File (PIF) for that cosmetic product. Under Article 11, the PIF must be retained for 10 years after the date on which the last batch of the product was placed on the market.
The PIF is expected to include, and be updated as necessary, information such as:
The PIF should be treated as a living compliance file, not a folder assembled once and forgotten. Formula changes, new safety information, revised claims or packaging updates may require the supporting record to be updated.
EU cosmetic manufacturing must comply with Good Manufacturing Practice. The PIF also includes a description of the manufacturing method and a statement of GMP compliance.
For U.S. brands, this means the manufacturing partner and regulatory team should be able to connect the final formula to documented production controls. Useful records may include approved manufacturing instructions, batch identification, raw material controls, in-process checks, finished-product specifications and quality records appropriate to the product.
When evaluating a manufacturing partner, the brand should understand which skincare formulation capabilities and quality processes are relevant to the formula being developed. The objective is consistency between the formula that was assessed, the formula that is notified and the product that is actually manufactured.
Packaging should not be finalized only from a U.S. artwork file. Article 19 of the Cosmetics Regulation establishes specific labeling information for cosmetics placed on the EU market.
Depending on the product, the label review should address items including:
Do not wait until finished cartons are printed to conduct the regulatory artwork review. A late label correction can affect production timing, packaging cost and inventory already in hand.
Claims should be reviewed alongside the formula and label, not added at the end of the project. Under the Regulation, the PIF includes proof of the effect claimed where justified by the nature or effect of the cosmetic product.
Keep the claims consistent with a cosmetic purpose. For example, language about appearance, cleansing, moisturizing or maintaining the skin in good condition is different from claims that present the product as treating or preventing disease. Strong performance claims may also require stronger substantiation.
Before launch, align:
The Cosmetic Products Notification Portal (CPNP) is the EU’s centralized electronic notification system for cosmetics. Regulation (EC) No 1223/2009 requires the Responsible Person—and distributors in certain circumstances—to submit specified product information through the portal before the product is placed on the EU market.
The European Commission states that once a product has been notified in CPNP, there is no need for an additional national cosmetic-product notification within the EU. However, CPNP notification does not replace the underlying safety, documentation, labeling and compliance obligations.
Information submitted under Article 13 includes items such as:
Products containing certain nanomaterials can have additional notification requirements under Article 16. That is another reason ingredient review should happen early rather than immediately before launch.
A product intended for both the United States and the EU may need parallel compliance workstreams. U.S. MoCRA obligations and EU Cosmetics Regulation obligations are not interchangeable, even when the same finished product is involved.
For the U.S. side, MedPak’s resource on U.S. MoCRA requirements covers the separate FDA registration and product-listing framework. For EU market entry, the brand should independently track the Responsible Person, CPSR, PIF, CPNP and EU labeling requirements described here.
This separation is useful operationally. It helps prevent teams from assuming that a U.S. registration, safety file or label automatically satisfies EU requirements—or vice versa.
☐ Final EU formula reviewed for prohibited, restricted and conditionally permitted ingredients.
☐ EU-based Responsible Person identified and documented.
☐ CPSR prepared by an appropriately qualified safety assessor.
☐ PIF assembled and location/access responsibility confirmed.
☐ Manufacturing method and GMP compliance documentation available.
☐ Stability, microbiological, compatibility and other relevant safety data available for the assessment.
☐ EU labeling reviewed before packaging is printed.
☐ Country-of-origin and Responsible Person details correctly shown where required.
☐ Marketing claims reviewed and supporting evidence retained.
☐ CPNP notification completed before the product is placed on the EU market.
☐ Nanomaterial requirements reviewed where applicable.
☐ Process established for complaints, serious undesirable effects and regulatory updates.
☐ Change-control process defined for future formula, supplier, packaging or claim revisions.
Ingredient restrictions and conditions can differ. Complete the EU formula review before final production and artwork.
The RP is connected to the PIF, CPNP and label. Delaying the appointment can hold up several downstream tasks.
The safety assessment may identify missing data or formulation issues that require action before launch.
The PIF is part of the compliance framework when the product is placed on the market. Assemble it as part of launch readiness.
Label changes after printing can create avoidable cost and delay.
Notification is one step. Product safety, documentation, GMP, labeling and claims still need to comply.
For U.S. beauty brands, EU market entry is easier to manage when compliance is built into product development instead of added after production. The formula, safety assessment, Responsible Person, PIF, label and CPNP submission are connected. A change in one area can affect several others.
MedPak Solutions can support brands with formulation, manufacturing documentation and product-development planning as they prepare for regulatory review and market launch. Regulatory responsibilities should still be confirmed for the specific product and target EU markets before commercialization.
Planning an EU launch? Contact MedPak Solutions to discuss your formula, production requirements and documentation needs.
Yes. A cosmetic product may be placed on the EU market only when a legal or natural person established in the EU is designated as the Responsible Person for that product. For imported cosmetics, the importer generally assumes that role unless another eligible person is designated by written mandate.
The Cosmetic Product Safety Report is the safety report required under Article 10 and Annex I of Regulation (EC) No 1223/2009. It is prepared as part of demonstrating that the cosmetic is safe for human health under normal or reasonably foreseeable conditions of use.
The Product Information File must be kept for 10 years after the date on which the last batch of the cosmetic product was placed on the market.
The Responsible Person must submit the required information electronically before the cosmetic product is placed on the EU market.
CPNP is a notification system used to implement the Cosmetics Regulation. A notification does not replace the separate obligations for product safety, the CPSR, PIF, GMP, labeling, ingredient restrictions and other applicable requirements.
Sometimes a common design can be adapted, but brands should not assume a U.S. label automatically meets EU requirements. Responsible Person information, imported-product origin, warnings, durability information, language requirements and other details should be reviewed for the intended EU markets.
